Dietary Bovine Lactoferrin Reduces the Deleterious Effects of Lipopolysaccharide Injection on Mice Intestine
Nutrients · 2024
DOI: 10.3390/nu16234040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Anne Blais und 5 weiteren Autor:innen. Beteiligte Einrichtung: UMR-PNCA, Université Paris-Saclay, AgroParisTech, INRAE, 91120 Palaiseau, France. Hauptthemen laut MEDLINE: Lactoferrin, Lipopolysaccharides, Dietary Supplements, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Soredab, LDT, La Tremblaye, 78125 La Boissière-Ecole, France, Soredab, AgroParisTech Paris-Saclay University.
Abstract (Originalsprache)
Background/Objectives: Injection of lipopolysaccharides (LPS) in experimental models induces a systemic inflammatory response that is associated with deleterious effects on intestinal morphology and physiology. In this study, we have studied in female mice the effects of dietary supplementation with bovine lactoferrin (bLF) given before intraperitoneal injection of LPS on jejunum and colon.
Methods
The first study evaluated the efficiency of different bLF and LPS concentrations to determine the optimal experimental conditions. For the second study mice were fed with 1% bLF before the LPS challenge (3 mg/kg body weight). Plasmatic markers of inflammation, intestinal morphology, permeability, and expression of genes related to epithelial differentiation, epithelial barrier function and intestinal inflammation in both small intestine and colon were evaluated. Results: bLF ingestion before the LPS challenge reduced the TNF-α circulating concentration, compared to control animals. This decrease in plasma TNF-α was correlated with improved intestinal permeability. The morphology of jejunal epithelium, which was affected by LPS challenge, was partly maintained by bLF. Measurement of the expression of genes encoding proteins involved in epithelial differentiation, intestinal inflammation, and epithelial barrier function suggests an overall protective effect of bLF against the adverse effects of LPS in the jejunum. In the colon, the effects of bLF ingestion on the subsequent LPS challenge, although protective, remain different when compared with those observed on jejunum.
Conclusions
Taken together, our data indicate that bLF dietary supplementation does have a protective effect on the deleterious intestinal alterations induced by LPS systemic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UMR-PNCA, Université Paris-Saclay, AgroParisTech, INRAE, 91120 Palaiseau, France.
- Soredab, LDT, La Tremblaye, 78125 La Boissière-Ecole, France.
ORCID-Profile: Anne Blais, Marta Grauso
Förderung
- Soredab, LDT, La Tremblaye, 78125 La Boissière-Ecole, France
- Soredab
- AgroParisTech Paris-Saclay University
Zitieren
APA
Blais, A., Takakura, N., Grauso, M., Puel-Artero, C., Blachier, F., & Lan, A. (2024). Dietary Bovine Lactoferrin Reduces the Deleterious Effects of Lipopolysaccharide Injection on Mice Intestine. Nutrients. https://doi.org/10.3390/nu16234040
Vancouver
Blais A, Takakura N, Grauso M, Puel-Artero C, Blachier F, Lan A. Dietary Bovine Lactoferrin Reduces the Deleterious Effects of Lipopolysaccharide Injection on Mice Intestine. Nutrients. 2024. doi:10.3390/nu16234040
BibTeX
@article{Blais2024,
author = {Blais, Anne and Takakura, Natsuko and Grauso, Marta and Puel-Artero, Caroline and Blachier, François and Lan, Annaïg},
title = {Dietary Bovine Lactoferrin Reduces the Deleterious Effects of Lipopolysaccharide Injection on Mice Intestine},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234040}
}
EUVIMED